Avenir Award Program for Chemistry and Pharmacology of Substance Use Disorders (DP1- Clinical Trial Not Allowed) (344128)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: Jul 9, 2023 (Letter of inquiry)

Later deadlines: Aug 9, 2023 (Full proposal), Jul 9, 2024 (Letter of inquiry), Aug 9, 2024 (Full proposal), Jul 7, 2025 (Letter of inquiry), Aug 7, 2025 (Full proposal)

Grant amount: Up to US $1,500,000

Fields of work: Addiction & Substance Use Disorders Pharmacology Biochemistry

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world

Overview:

The goal of this FOA is to attract outstanding early-stage investigators to the field of chemistry and pharmacology of substance used disorders. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow's leaders in the field. In recent years, there have been significant advances in methods and technologies for the identification of novel targets, mechanisms, and pathways of interest to substance use disorders and in identification of probes and optimized compounds for developing novel therapeutic agents. This FOA is to enable investigators with knowledge in the emerging chemical, pharmacological, and drug discovery technologies to pursue innovative and transformative research on chemical and pharmacological aspects of substance use disorders.

Application budgets are limited to $300,000 in Direct Costs each year for up to five years.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed October 21, 2022 and last updated October 21, 2022